UroGen Pharma (URGN) Tops Q1 EPS by 12c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Boeing free cash flow beats estimates despite production challenges
| (NASDAQ: URGN) | Delayed: 34.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.04 | 52 Week High | $ | |||
| Open | $34.04 | 52 Week Low | $ | |||
| Day High | $34.04 | P/E | N/A | |||
| Day Low | $34.04 | EPS | $ | |||
| Volume | 29,281 | |||||
